Ozempic, also known as semaglutide, is a medication used to improve glycemic control in adults with type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Ozempic is typically used in the following ways in therapy:

1. Glycemic Control: Ozempic is primarily used to help control blood sugar levels in patients with type 2 diabetes. It works by mimicking the functions of natural hormones in the body to regulate blood sugar levels.

2. Weight Management: In addition to its blood sugar-lowering effects, Ozempic has been shown to aid in weight loss. It helps patients feel full and satisfied, which can lead to reduced food intake and weight loss.

3. Cardiovascular Risk Reduction: Ozempic has been shown to reduce the risk of major adverse cardiovascular events, such as heart attack and stroke, in patients with type 2 diabetes and established cardiovascular disease.

4. Once-Weekly Dosing: Ozempic is administered via subcutaneous injection once a week, making it a convenient option for patients.

According to DrugPatentWatch.com, Ozempic is currently patent-protected in the United States until 2030, meaning that generic versions of the drug are not yet available.

Sources:

1. [DrugPatentWatch.com](https://www.drugpatentwatch.com/drugs/ozempic)